Y
Yesim Kirazli
Researcher at Ege University
Publications - 53
Citations - 5919
Yesim Kirazli is an academic researcher from Ege University. The author has contributed to research in topics: Osteoporosis & Rehabilitation. The author has an hindex of 22, co-authored 51 publications receiving 5027 citations. Previous affiliations of Yesim Kirazli include American Physical Therapy Association.
Papers
More filters
Journal ArticleDOI
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
Martin Rudwaleit,D. van der Heijde,Robert Landewé,Joachim Listing,Nurullah Akkoc,J Brandt,Jürgen Braun,C.T. Chou,Eduardo Collantes-Estevez,Maxime Dougados,Feng Huang,Jieruo Gu,Muhammad Asim Khan,Yesim Kirazli,Walter P. Maksymowych,Herman Mielants,Inge Juul Sørensen,Salih Ozgocmen,Euthalia Roussou,R. Valle-Oñate,Ulrich Weber,James Cheng-Chung Wei,Joachim Sieper +22 more
TL;DR: The new ASAS classification criteria for axial SpA can reliably classify patients for clinical studies and may help rheumatologists in clinical practice in diagnosing axial spondyloarthritis in those with chronic back pain.
Journal ArticleDOI
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
Martin Rudwaleit,D. van der Heijde,Robert Landewé,Nurullah Akkoc,J Brandt,C.T. Chou,Maxime Dougados,Feng Huang,Jieruo Gu,Yesim Kirazli,F. Van den Bosch,Ivana Olivieri,Euthalia Roussou,Salvatore Scarpato,Inge Juul Sørensen,R. Valle-Oñate,Ulrich Weber,James Cheng-Chung Wei,J. Sieper +18 more
TL;DR: The new ASAS classification criteria for peripheral SpA performed well in patients presenting with peripheral arthritis, enthesitis and/or dactylitis, particularly regarding sensitivity.
Journal ArticleDOI
European Consensus Table On the Use of Botulinum Toxin Type a in Adult Spasticity
Jörg Wissel,Anthony B. Ward,Per Erztgaard,Djamel Bensmail,Martin J Hecht,Thierry Lejeune,Peter Schnider,Maria C. Altavista,Stefano Cavazza,Thierry Deltombe,Esther Duarte,Alexander C. H. Geurts,Jean-Michel Gracies,Naseer H J Haboubi,Francisco J. Juan,Helge Kasch,Christian Kätterer,Yesim Kirazli,Paolo Manganotti,Yesim Parman,Tatjana Paternostro-Sluga,Konstantina Petropoulou,Robert Prempeh,Marc Rousseaux,Jarosław Sławek,Niko Tieranta +25 more
TL;DR: A group of clinicians from across Europe experienced in the use of botulinum toxin type A for the treatment of spasticity following acquired brain injury gathered to develop a consensus statement on best practice in managing adults withSpasticity.
Journal ArticleDOI
A turkish version of the bath ankylosing spondylitis disease activity index : reliability and validity
TL;DR: The results of this study show that the Turkish version of the BASDAI is reliable, valid, and sensitive to change.
Journal ArticleDOI
Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial.
TL;DR: It is concluded that both motor point injections with botulinus toxin Type A and tibial nerve blockade with phenol are effective in plantar flexor spasticity, but the changes were more significant in the group that receivedBotulinus toxins Type A at Weeks 2 and 4, whereas there was not a significant difference between the two groups at Weeks 8 and 12.